68Ga-NOTA-SCH001
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 68Ga-NOTA-SCH001, covering 2025-04-13 to 2025-04-13. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Trial Evaluating the Safety Tolerability, Radiation Absorption Dose, Distribution, PET Imaging and Histological Expression of 68Ga-NOTA-SCH001 in Patients With Multiple Myeloma [NA]